MAPT and Cognitive impairment: In this study, the alteration of NLRP3 levels was not obvious, but the NLRP3 inflammasome was activated 7 m post injection, and cognitive impairment appeared, indicating that it may be a major contributor to the elevation in HMGB1 and abnormal cognition resulting from tau overexpression.